Kenneth M Rosenberg, David N Blitzer, Sarah Rosenberger, Mirnal Chaudhary, Rajabrata Sarkar
{"title":"增强术后恢复方案减少住院时间和术后阿片类药物用于胸廓出口综合征手术减压","authors":"Kenneth M Rosenberg, David N Blitzer, Sarah Rosenberger, Mirnal Chaudhary, Rajabrata Sarkar","doi":"10.1016/j.jvs.2025.05.013","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>First rib resection for thoracic outlet syndrome (TOS) requires inpatient hospital stay and causes post-operative pain. We hypothesized that an enhanced recovery after surgery (ERAS) protocol, including multimodal pain management, would reduce post-operative narcotic use and length of stay (LOS).</p><p><strong>Methods: </strong>A retrospective single center case-control study (2016-2022) compared three protocols: 1) conventional peri-operative and pain management, 2) multimodal pain management with implantation of ropivacaine pump, and 3) ERAS peri-operative protocol including ropivacaine pump. Primary (inpatient opioid use and LOS) and secondary outcomes (complications and hospital cost) were assessed.</p><p><strong>Results: </strong>98 patients were evaluated (107 first rib resections). Compared to conventional pain management (median 33 mg/d), daily opioid use significantly decreased with both multimodal pain management alone (14 mg/d, P<0.0001) and full ERAS protocol (11 mg/d, P<0.0001). ERAS patients had shorter LOS than conventional management (1.44 d vs. 3.26 d, P<0.0001), but multimodal pain management alone did not. Complication rates were similar among the three groups, although ERAS patients had increased post-operative ED visits (n=4 (7.4%) vs. n=7 (27%), P=0.024) and readmissions (n=2 (3.7%) vs. n=5 (19%), P=0.034). Index hospital admission cost decreased between the ERAS and conventional groups (mean: $9,327 vs. $13,053, P=0.012). Total hospital cost including ED visits and readmissions, however, was similar between the three protocols.</p><p><strong>Conclusions: </strong>Consistent with other areas of surgery, ERAS yielded a >2-fold decrease in LOS, multimodal pain management alone decreased opioid use, but did not reduce LOS. ERAS protocol increased ED visits and readmissions, suggesting that optimization to decrease readmissions will improve care and lower costs.</p>","PeriodicalId":17475,"journal":{"name":"Journal of Vascular Surgery","volume":" ","pages":""},"PeriodicalIF":3.9000,"publicationDate":"2025-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Enhanced Recovery After Surgery Protocol Decreases Hospital Length of Stay and Post-Operative Opioid Use for Thoracic Outlet Syndrome Surgical Decompression.\",\"authors\":\"Kenneth M Rosenberg, David N Blitzer, Sarah Rosenberger, Mirnal Chaudhary, Rajabrata Sarkar\",\"doi\":\"10.1016/j.jvs.2025.05.013\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>First rib resection for thoracic outlet syndrome (TOS) requires inpatient hospital stay and causes post-operative pain. We hypothesized that an enhanced recovery after surgery (ERAS) protocol, including multimodal pain management, would reduce post-operative narcotic use and length of stay (LOS).</p><p><strong>Methods: </strong>A retrospective single center case-control study (2016-2022) compared three protocols: 1) conventional peri-operative and pain management, 2) multimodal pain management with implantation of ropivacaine pump, and 3) ERAS peri-operative protocol including ropivacaine pump. Primary (inpatient opioid use and LOS) and secondary outcomes (complications and hospital cost) were assessed.</p><p><strong>Results: </strong>98 patients were evaluated (107 first rib resections). Compared to conventional pain management (median 33 mg/d), daily opioid use significantly decreased with both multimodal pain management alone (14 mg/d, P<0.0001) and full ERAS protocol (11 mg/d, P<0.0001). ERAS patients had shorter LOS than conventional management (1.44 d vs. 3.26 d, P<0.0001), but multimodal pain management alone did not. Complication rates were similar among the three groups, although ERAS patients had increased post-operative ED visits (n=4 (7.4%) vs. n=7 (27%), P=0.024) and readmissions (n=2 (3.7%) vs. n=5 (19%), P=0.034). Index hospital admission cost decreased between the ERAS and conventional groups (mean: $9,327 vs. $13,053, P=0.012). Total hospital cost including ED visits and readmissions, however, was similar between the three protocols.</p><p><strong>Conclusions: </strong>Consistent with other areas of surgery, ERAS yielded a >2-fold decrease in LOS, multimodal pain management alone decreased opioid use, but did not reduce LOS. ERAS protocol increased ED visits and readmissions, suggesting that optimization to decrease readmissions will improve care and lower costs.</p>\",\"PeriodicalId\":17475,\"journal\":{\"name\":\"Journal of Vascular Surgery\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.9000,\"publicationDate\":\"2025-05-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Vascular Surgery\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.jvs.2025.05.013\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PERIPHERAL VASCULAR DISEASE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Vascular Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jvs.2025.05.013","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
Enhanced Recovery After Surgery Protocol Decreases Hospital Length of Stay and Post-Operative Opioid Use for Thoracic Outlet Syndrome Surgical Decompression.
Objective: First rib resection for thoracic outlet syndrome (TOS) requires inpatient hospital stay and causes post-operative pain. We hypothesized that an enhanced recovery after surgery (ERAS) protocol, including multimodal pain management, would reduce post-operative narcotic use and length of stay (LOS).
Methods: A retrospective single center case-control study (2016-2022) compared three protocols: 1) conventional peri-operative and pain management, 2) multimodal pain management with implantation of ropivacaine pump, and 3) ERAS peri-operative protocol including ropivacaine pump. Primary (inpatient opioid use and LOS) and secondary outcomes (complications and hospital cost) were assessed.
Results: 98 patients were evaluated (107 first rib resections). Compared to conventional pain management (median 33 mg/d), daily opioid use significantly decreased with both multimodal pain management alone (14 mg/d, P<0.0001) and full ERAS protocol (11 mg/d, P<0.0001). ERAS patients had shorter LOS than conventional management (1.44 d vs. 3.26 d, P<0.0001), but multimodal pain management alone did not. Complication rates were similar among the three groups, although ERAS patients had increased post-operative ED visits (n=4 (7.4%) vs. n=7 (27%), P=0.024) and readmissions (n=2 (3.7%) vs. n=5 (19%), P=0.034). Index hospital admission cost decreased between the ERAS and conventional groups (mean: $9,327 vs. $13,053, P=0.012). Total hospital cost including ED visits and readmissions, however, was similar between the three protocols.
Conclusions: Consistent with other areas of surgery, ERAS yielded a >2-fold decrease in LOS, multimodal pain management alone decreased opioid use, but did not reduce LOS. ERAS protocol increased ED visits and readmissions, suggesting that optimization to decrease readmissions will improve care and lower costs.
期刊介绍:
Journal of Vascular Surgery ® aims to be the premier international journal of medical, endovascular and surgical care of vascular diseases. It is dedicated to the science and art of vascular surgery and aims to improve the management of patients with vascular diseases by publishing relevant papers that report important medical advances, test new hypotheses, and address current controversies. To acheive this goal, the Journal will publish original clinical and laboratory studies, and reports and papers that comment on the social, economic, ethical, legal, and political factors, which relate to these aims. As the official publication of The Society for Vascular Surgery, the Journal will publish, after peer review, selected papers presented at the annual meeting of this organization and affiliated vascular societies, as well as original articles from members and non-members.